RETATRUTIDE - 46 Anuncios

China 401120 Materias primeras
Retatrutide

Friday 29 August 2025

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Chongqing Soarwin Technology Co., Ltd

  • 401120 - chongqing
  • +18 0 99 30 10 07
  • +86 19944061337
China 401120 Materias primeras
Retatrutide

Wednesday 20 August 2025

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Chongqing Soarwin Technology Co., Ltd

  • 401120 - chongqing
  • +18 0 99 30 10 07
  • +86 19944061337
China 401120 Medicina
Retatrutide Polypeptide Pharmaceutical Intermediate Medical Care

Thursday 14 August 2025

Cantidad : 60mg*10via - Precio : USD 650

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Chongqing Soarwin Technology Co., Ltd

  • 401120 - Chongqing
  • +17 3 16 83 50 63
China 401120 Medicina
Retatrutide Polypeptide Pharmaceutical Intermediate Medical Care

Wednesday 13 August 2025

Cantidad : 60mg*10via - Precio : USD 650

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Chongqing Soarwin Technology Co., Ltd

  • 401120 - Chongqing
  • +17 3 16 83 50 63
China 401120 Medicina
Retatrutide Polypeptide Pharmaceutical Intermediate Medical Care

Wednesday 13 August 2025

Cantidad : 50mg*10via - Precio : USD 550

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Chongqing Soarwin Technology Co., Ltd

  • 401120 - Chongqing
  • +17 3 16 83 50 63
China 401120 Medicina
Retatrutide Polypeptide Pharmaceutical Intermediate Medical Care

Wednesday 13 August 2025

Cantidad : 40mg*10via - Precio : USD 450

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Chongqing Soarwin Technology Co., Ltd

  • 401120 - Chongqing
  • +17 3 16 83 50 63
China 401120 Medicina
Retatrutide Polypeptide Pharmaceutical Intermediate Medical Care

Wednesday 13 August 2025

Cantidad : 30mg*10via - Precio : USD 360

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Chongqing Soarwin Technology Co., Ltd

  • 401120 - Chongqing
  • +17 3 16 83 50 63
China 401120 Medicina
Retatrutide Polypeptide Pharmaceutical Intermediate Medical Care

Wednesday 13 August 2025

Cantidad : 20mg*10via - Precio : USD 300

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Chongqing Soarwin Technology Co., Ltd

  • 401120 - Chongqing
  • +17 3 16 83 50 63
China 401120 Medicina
Retatrutide Polypeptide Pharmaceutical Intermediate Medical Care

Wednesday 13 August 2025

Cantidad : 15mg*10via - Precio : USD 230

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Chongqing Soarwin Technology Co., Ltd

  • 401120 - Chongqing
  • +17 3 16 83 50 63
China 401120 Medicina
Retatrutide Polypeptide Pharmaceutical Intermediate Medical Care

Wednesday 13 August 2025

Cantidad : 10mg*10via - Precio : USD 180

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Chongqing Soarwin Technology Co., Ltd

  • 401120 - Chongqing
  • +17 3 16 83 50 63
China 401120 Medicina
Retatrutide

Wednesday 13 August 2025

Cantidad : 5mg*10vial - Precio : USD 130

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Chongqing Soarwin Technology Co., Ltd

  • 401120 - Chongqing
  • +17 3 16 83 50 63
China 401120 Medicina
Retatrutide Polypeptide Pharmaceutical Intermediate Medical Care

Tuesday 12 August 2025

Cantidad : 15mg*10via - Precio : USD 230

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Chongqing Soarwin Technology Co., Ltd

  • 401120 - Chongqing
  • +17 3 16 83 50 63
China 401120 Medicina
Retatrutide Polypeptide Pharmaceutical Intermediate Medical Care

Tuesday 12 August 2025

Cantidad : 10mg*10via - Precio : USD 180

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Chongqing Soarwin Technology Co., Ltd

  • 401120 - Chongqing
  • +17 3 16 83 50 63
China 401120 Medicina
Retatrutide Polypeptide Pharmaceutical Intermediate Medical Care

Tuesday 12 August 2025

Cantidad : 5mg*10vial - Precio : USD 130

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Chongqing Soarwin Technology Co., Ltd

  • 401120 - Chongqing
  • +17 3 16 83 50 63
China 401120 Medicina
Retatrutide Polypeptide Pharmaceutical Intermediate Medical Care

Saturday 09 August 2025

Cantidad : 15mg*10via - Precio : USD 230

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Chongqing Soarwin Technology Co., Ltd

  • 401120 - Chongqing
  • +17 3 16 83 50 63
China 401120 Medicina
Retatrutide Polypeptide Pharmaceutical Intermediate Medical Care

Saturday 09 August 2025

Cantidad : 10mg*10via - Precio : USD 180

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Chongqing Soarwin Technology Co., Ltd

  • 401120 - Chongqing
  • +17 3 16 83 50 63
China 401120 Medicina
Retatrutide Polypeptide Pharmaceutical Intermediate Medical Care

Wednesday 06 August 2025

Cantidad : 5mg*10vial - Precio : USD 130

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Chongqing Soarwin Technology Co., Ltd

  • 401120 - Chongqing
  • +17 3 16 83 50 63
China 401120 Medicina
Retatrutide Polypeptide Pharmaceutical Intermediate Medical Care

Tuesday 05 August 2025

Cantidad : 30mg*10via - Precio : USD 360

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Chongqing Soarwin Technology Co., Ltd

  • 401120 - Chongqing
  • +17 3 16 83 50 63
China 401120 Medicina
Retatrutide Polypeptide Pharmaceutical Intermediate Medical Care

Tuesday 05 August 2025

Cantidad : 5mg*10vial - Precio : USD 130

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Chongqing Soarwin Technology Co., Ltd

  • 401120 - Chongqing
  • +17 3 16 83 50 63
China 401120 Materias primeras
Retatrutide

Friday 01 August 2025

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Chongqing Soarwin Technology Co., Ltd

  • 401120 - chongqing
  • +18 0 99 30 10 07
  • +86 19944061337
China 401120 Medicina
Retatrutide Polypeptide Pharmaceutical Intermediate Medical Care

Thursday 31 July 2025

Cantidad : 20mg*10via - Precio : USD 300

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Chongqing Soarwin Technology Co., Ltd

  • 401120 - Chongqing
  • +17 3 16 83 50 63
China 401120 Medicina
Retatrutide Polypeptide Pharmaceutical Intermediate Medical Care

Thursday 31 July 2025

Cantidad : 15mg*10via - Precio : USD 230

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Chongqing Soarwin Technology Co., Ltd

  • 401120 - Chongqing
  • +17 3 16 83 50 63
China 401120 Medicina
Retatrutide Polypeptide Pharmaceutical Intermediate Medical Care

Thursday 31 July 2025

Cantidad : 10mg*10via - Precio : USD 180

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Chongqing Soarwin Technology Co., Ltd

  • 401120 - Chongqing
  • +17 3 16 83 50 63
China 401120 Medicina
Retatrutide Polypeptide Pharmaceutical Intermediate Medical Care

Thursday 31 July 2025

Cantidad : 5mg*10vial - Precio : USD 130

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Chongqing Soarwin Technology Co., Ltd

  • 401120 - Chongqing
  • +17 3 16 83 50 63
China 401120 Medicina
Retatrutide Polypeptide Pharmaceutical Intermediate Medical Care

Tuesday 29 July 2025

Cantidad : 60mg*10via - Precio : USD 650

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Chongqing Soarwin Technology Co., Ltd

  • 401120 - Chongqing
  • +17 3 16 83 50 63
China 401120 Medicina
Retatrutide Polypeptide Pharmaceutical Intermediate Medical Care

Tuesday 29 July 2025

Cantidad : 50mg*10via - Precio : USD 550

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Chongqing Soarwin Technology Co., Ltd

  • 401120 - Chongqing
  • +17 3 16 83 50 63
China 401120 Medicina
Retatrutide Polypeptide Pharmaceutical Intermediate Medical Care

Tuesday 29 July 2025

Cantidad : 40mg*10via - Precio : USD 450

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Chongqing Soarwin Technology Co., Ltd

  • 401120 - Chongqing
  • +17 3 16 83 50 63
China 401120 Medicina
Retatrutide Polypeptide Pharmaceutical Intermediate Medical Care

Tuesday 29 July 2025

Cantidad : 30mg*10via - Precio : USD 360

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Chongqing Soarwin Technology Co., Ltd

  • 401120 - Chongqing
  • +17 3 16 83 50 63
China 401120 Medicina
Retatrutide Polypeptide Pharmaceutical Intermediate Medical Care

Tuesday 29 July 2025

Cantidad : 20mg*10via - Precio : USD 300

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Chongqing Soarwin Technology Co., Ltd

  • 401120 - Chongqing
  • +17 3 16 83 50 63
China 401120 Medicina
Retatrutide Polypeptide Pharmaceutical Intermediate Medical Care

Tuesday 29 July 2025

Cantidad : 15mg*10via - Precio : USD 230

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Chongqing Soarwin Technology Co., Ltd

  • 401120 - Chongqing
  • +17 3 16 83 50 63
Nombre de resultados por pàgina : 6 30 150

Búsqueda RETATRUTIDE


Búsqueda ayuda

  • Los resultados contienen todas las palabras, independientemente de la capitalización. Por ejemplo, la búsqueda de Perro Gato devuelve todos los resultados que contengan esas dos palabras.
  • Las comillas (") permite búsquedas de frases. En este caso, la búsqueda de "perro gato" devuelve todos los mensajes que contengan la frase exacta, con espacio.
  • El signo menos (-) elimina palabras. En este caso, la búsqueda de perro y gato devuelve todos los mensajes que contienen perro pero no gato. Usted puede poner un signo menos (-) delante de una frase entre comillas ("), como perro -"gato siamés".